499
Participants
Start Date
September 30, 2010
Primary Completion Date
April 30, 2012
Placebo
Placebo tablets matching BI 10773 low dose
BI 10773
BI 10773 tablets once daily
Placebo
Placebo tablets matching BI 10773 high dose
Placebo
Placebo tablets matching BI 10773 high dose
Placebo
Placebo tablets matching BI 10773 high dose
BI 10773
BI 10773 tablets once daily
1245.19.10056 Boehringer Ingelheim Investigational Site, Muscle Shoals
1245.19.10162 Boehringer Ingelheim Investigational Site, Glendale
1245.19.10161 Boehringer Ingelheim Investigational Site, Phoenix
1245.19.10046 Boehringer Ingelheim Investigational Site, Tempe
1245.19.10070 Boehringer Ingelheim Investigational Site, Irvine
1245.19.10047 Boehringer Ingelheim Investigational Site, La Mesa
1245.19.10149 Boehringer Ingelheim Investigational Site, Rancho Cucamonga
1245.19.10163 Boehringer Ingelheim Investigational Site, Riverside
1245.19.10131 Boehringer Ingelheim Investigational Site, West Hills
1245.19.10141 Boehringer Ingelheim Investigational Site, Milford
1245.19.10133 Boehringer Ingelheim Investigational Site, Jupiter
1245.19.10085 Boehringer Ingelheim Investigational Site, Plantation
1245.19.10077 Boehringer Ingelheim Investigational Site, Perry
1245.19.10014 Boehringer Ingelheim Investigational Site, Dubuque
1245.19.10160 Boehringer Ingelheim Investigational Site, Essex
1245.19.10003 Boehringer Ingelheim Investigational Site, Dearborn
1245.19.10059 Boehringer Ingelheim Investigational Site, New Hyde Park
1245.19.10123 Boehringer Ingelheim Investigational Site, Smithtown
1245.19.10071 Boehringer Ingelheim Investigational Site, Asheboro
1245.19.10086 Boehringer Ingelheim Investigational Site, Salisbury
1245.19.10008 Boehringer Ingelheim Investigational Site, Marion
1245.19.10033 Boehringer Ingelheim Investigational Site, Chattanooga
1245.19.10112 Boehringer Ingelheim Investigational Site, Memphis
1245.19.10002 Boehringer Ingelheim Investigational Site, Norfolk
1245.19.20047 Boehringer Ingelheim Investigational Site, Vancouver
1245.19.20062 Boehringer Ingelheim Investigational Site, Vancouver
1245.19.20012 G.A. Research Associates Ltd., Moncton
1245.19.20031 Boehringer Ingelheim Investigational Site, St. John's
1245.19.20057 Boehringer Ingelheim Investigational Site, Brampton
1245.19.20059 Boehringer Ingelheim Investigational Site, Fort Erie
1245.19.20060 Boehringer Ingelheim Investigational Site, London
1245.19.20009 Boehringer Ingelheim Investigational Site, Newmarket
1245.19.20034 Boehringer Ingelheim Investigational Site, Sarnia
1245.19.20058 Boehringer Ingelheim Investigational Site, Saint Romuald
1245.19.20041 Boehringer Ingelheim Investigational Site, Saskatoon
1245.19.30002 Boehringer Ingelheim Investigational Site, Athens
1245.19.30001 Boehringer Ingelheim Investigational Site, Nikaia
1245.19.30004 Boehringer Ingelheim Investigational Site, Thessaloniki
1245.19.91005 Boehringer Ingelheim Investigational Site, Bangalore
1245.19.91006 Boehringer Ingelheim Investigational Site, Bangalore
1245.19.91008 Boehringer Ingelheim Investigational Site, Bangalore
1245.19.91003 Boehringer Ingelheim Investigational Site, Belagavi
1245.19.91004 Boehringer Ingelheim Investigational Site, Chennai
1245.19.91009 Boehringer Ingelheim Investigational Site, Chennai
1245.19.91001 Boehringer Ingelheim Investigational Site, Coimbatore
1245.19.91015 Boehringer Ingelheim Investigational Site, Kalaburagi
1245.19.91011 Boehringer Ingelheim Investigational Site, Kartanaka
1245.19.91002 Boehringer Ingelheim Investigational Site, Mumbai
1245.19.91007 Boehringer Ingelheim Investigational Site, Mumbai, Maharastra
1245.19.91017 Boehringer Ingelheim Investigational Site, Mysore
1245.19.91010 Boehringer Ingelheim Investigational Site, Nagpur
1245.19.91012 Boehringer Ingelheim Investigational Site, New Delhi
1245.19.91013 Boehringer Ingelheim Investigational Site, Patna
1245.19.91014 Boehringer Ingelheim Investigational Site, Pune
1245.19.91016 Boehringer Ingelheim Investigational Site, Pune
1245.19.63002 Boehringer Ingelheim Investigational Site, Cebu City, N/A, Philippines
1245.19.63003 Boehringer Ingelheim Investigational Site, Davao City, N/A, Philippines
1245.19.63004 Boehringer Ingelheim Investigational Site, Manila, Philippines
1245.19.63005 Boehringer Ingelheim Investigational Site, Pasig City, Philippines
1245.19.63001 Boehringer Ingelheim Investigational Site, San Juan City, Philippines
1245.19.66003 Boehringer Ingelheim Investigational Site, Saimai
1245.19.66004 Boehringer Ingelheim Investigational Site, Udon Thani, Thailand
1245.19.75002 Boehringer Ingelheim Investigational Site, Dnipro
1245.19.75001 Boehringer Ingelheim Investigational Site, Kharkiv
1245.19.75005 Boehringer Ingelheim Investigational Site, Kiev
1245.19.75006 Boehringer Ingelheim Investigational Site, Lviv
1245.19.75004 Boehringer Ingelheim Investigational Site, Vinnitsa
1245.19.75003 Boehringer Ingelheim Investigational Site, Vinnytsia
Lead Sponsor
Eli Lilly and Company
INDUSTRY
Boehringer Ingelheim
INDUSTRY